A detailed history of Private Management Group Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Private Management Group Inc holds 122,500 shares of JNJ stock, worth $19 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
122,500
Previous 123,336 0.68%
Holding current value
$19 Million
Previous $18 Million 10.13%
% of portfolio
0.76%
Previous 0.73%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$145.48 - $167.38 $121,621 - $139,929
-836 Reduced 0.68%
122,500 $19.9 Million
Q2 2024

Aug 06, 2024

BUY
$144.38 - $157.78 $7.72 Million - $8.43 Million
53,452 Added 76.49%
123,336 $18 Million
Q1 2024

May 08, 2024

SELL
$155.22 - $162.74 $617,154 - $647,054
-3,976 Reduced 5.38%
69,884 $11.1 Million
Q4 2023

Feb 01, 2024

SELL
$145.6 - $158.88 $103,521 - $112,963
-711 Reduced 0.95%
73,860 $11.6 Million
Q3 2023

Oct 30, 2023

SELL
$155.75 - $174.48 $1.92 Million - $2.16 Million
-12,351 Reduced 14.21%
74,571 $11.6 Million
Q2 2023

Aug 07, 2023

SELL
$154.35 - $166.11 $224,116 - $241,191
-1,452 Reduced 1.64%
86,922 $14.4 Million
Q1 2023

May 08, 2023

SELL
$151.05 - $180.26 $1.81 Million - $2.16 Million
-11,987 Reduced 11.94%
88,374 $13.7 Million
Q4 2022

Feb 02, 2023

SELL
$160.2 - $179.79 $3.72 Million - $4.17 Million
-23,193 Reduced 18.77%
100,361 $17.7 Million
Q3 2022

Feb 06, 2023

BUY
$161.33 - $179.52 $3.74 Million - $4.16 Million
23,193 Added 23.11%
123,554 $20.2 Million
Q3 2022

Feb 06, 2023

BUY
$161.33 - $179.52 $3.74 Million - $4.16 Million
23,193 Added 23.11%
123,554 $20.2 Million
Q3 2022

Nov 08, 2022

SELL
$161.33 - $179.52 $2.13 Million - $2.37 Million
-13,209 Reduced 9.66%
123,554 $20.2 Million
Q2 2022

Aug 05, 2022

SELL
$168.19 - $186.01 $400,292 - $442,703
-2,380 Reduced 1.71%
136,763 $24.3 Million
Q1 2022

May 06, 2022

SELL
$158.14 - $179.59 $257,610 - $292,552
-1,629 Reduced 1.16%
139,143 $24.7 Million
Q4 2021

Feb 08, 2022

SELL
$155.93 - $173.01 $30,874 - $34,255
-198 Reduced 0.14%
140,772 $24.1 Million
Q3 2021

Nov 09, 2021

SELL
$161.5 - $179.47 $333,497 - $370,605
-2,065 Reduced 1.44%
140,970 $22.8 Million
Q2 2021

Jul 23, 2021

SELL
$159.48 - $171.07 $468,552 - $502,603
-2,938 Reduced 2.01%
143,035 $23.6 Million
Q1 2021

May 11, 2021

SELL
$153.07 - $170.48 $511,866 - $570,085
-3,344 Reduced 2.24%
145,973 $24 Million
Q4 2020

Feb 03, 2021

BUY
$137.11 - $157.38 $6.87 Million - $7.88 Million
50,092 Added 50.48%
149,317 $23.5 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $2.19 Million - $2.39 Million
15,566 Added 18.61%
99,225 $14.8 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $6.81 Million - $8.22 Million
52,882 Added 171.82%
83,659 $11.8 Million
Q1 2020

May 13, 2020

BUY
$111.14 - $153.99 $3 Million - $4.15 Million
26,966 Added 707.58%
30,777 $4.04 Million
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $7,395 - $8,493
58 Added 1.55%
3,811 $556,000
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $6,855 - $7,675
54 Added 1.46%
3,753 $486,000
Q2 2019

Aug 12, 2019

BUY
$131.15 - $144.24 $43,935 - $48,320
335 Added 9.96%
3,699 $515,000
Q1 2019

May 10, 2019

SELL
$125.72 - $139.79 $10,686 - $11,882
-85 Reduced 2.46%
3,364 $470,000
Q4 2018

Feb 06, 2019

BUY
$122.84 - $147.84 $58,349 - $70,224
475 Added 15.97%
3,449 $445,000
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $19,574 - $23,003
-161 Reduced 5.14%
2,974 $411,000
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $51,103 - $56,393
428 Added 15.81%
3,135 $380,000
Q1 2018

May 11, 2018

SELL
$125.1 - $148.14 $116,718 - $138,214
-933 Reduced 25.63%
2,707 $347,000
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $26,506 - $29,011
-202 Reduced 5.26%
3,640 $509,000
Q3 2017

Nov 07, 2017

SELL
$129.47 - $135.38 $1.39 Million - $1.45 Million
-10,744 Reduced 73.66%
3,842 $499,000
Q2 2017

Aug 09, 2017

BUY
N/A
14,586
14,586 $1.93 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Private Management Group Inc Portfolio

Follow Private Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Management Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Private Management Group Inc with notifications on news.